| Literature DB >> 33228046 |
Florent Besnier1,2, Béatrice Bérubé1,3, Christine Gagnon1,2,3, Miloudza Olmand1,2, Paula Aver Bretanha Ribeiro4, Anil Nigam1,2, Martin Juneau1,2, Lucie Blondeau5, Michel White1,2, Vincent Gremeaux6, Louis Bherer1,2,3, Mathieu Gayda1,2.
Abstract
We compared cognitive profiles in chronic heart failure patients (HF), heart transplant recipients (HT) and healthy controls (HC) and examined the relationship between cardiorespiratory fitness (V˙O2peak), peak cardiac output (COpeak) and cognitive performance. Stable HT patients (n = 11), HF patients (n = 11) and HC (n = 13) (61.5 ± 8.5 years) were recruited. Four cognitive composite scores targeting different cognitive functions were computed from neuropsychological tests: working memory, processing speed, executive functions and verbal memory. Processing speed and executive function scores were higher, which indicates lower performances in HF and HT compared to HC (p < 0.05). V˙O2peak and first ventilatory threshold (VT1) were lower in HF and HT vs. HC (p < 0.01). COpeak was lower in HF vs. HT and HC (p < 0.01). Processing speed, executive function and verbal memory performances were correlated with V˙O2peak, VT1 and peak cardiac hemodynamics (p < 0.05). Mediation analyses showed that V˙O2peak and VT1 mediated the relationship between group and processing speed and executive function performances in HF and HT. COpeak fully mediated executive function and processing speed performances in HF only. V˙O2peak and COpeak were related to cognitive performance in the entire sample. In addition, V˙O2peak and VT1 fully mediated the relationship between group and executive function and processing speed performances.Entities:
Keywords: cardiorespiratory fitness; cognition; heart failure; heart transplant
Year: 2020 PMID: 33228046 PMCID: PMC7699401 DOI: 10.3390/ijerph17228591
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Baseline clinical and sociodemographic characteristics in healthy controls (HC), heart failure patients (HF) and heart transplant recipient (HT) participants.
| HF | HT | HC | ||
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Age (years) | 66.18 ± 7.88 | 58.55 ± 7.92 | 60.15 ± 8.49 | 0.081 |
| Sex (F/M) | 1/10 | 1/10 | 1/12 | - |
| Heigh (cm) | 172.45 ± 8.26 | 169.73 ± 7.36 | 172.69 ± 8.28 | 0.621 |
| Body mass (kg) | 77.38 ± 10.91 | 78.07 ± 15.85 | 73.53 ± 8.09 | 0.532 |
| BMI (kg/m2) | 25.97 ± 2.89 | 27.04 ± 4.95 | 24.65 ± 2.03 | 0.236 |
| Body surface (m2) | 1.92 ± 0.17 | 1.91 ± 0.21 | 1.88 ± 0.14 | 0.796 |
| Level of education (years) | 14.36 ± 3.83 | 11.82 ± 3.09 | 14.67 ± 2.67 | 0.086 |
| Time from transplantation (years) | - | 7.40 ± 5.40 | - | - |
| Medication | ||||
| Immunosuppressive drugs * | 11 (100%) | |||
| Beta blockers | 11 (100%) | 3 (27%) | ||
| ACE inhibitors | 6 (55%) | 0 | ||
| ARBs | 6 (55%) | 6 (55%) | ||
| Diuretics | 9 (82%) |
BMI: body mass index, ACE: angiotensin I-converting enzyme, ARBs: angiotensin receptor blockers, * Rapamycine, Myfortic, Prograf, Cyclosporine, Cellecept, Tacrolimus.
Cardiopulmonary exercise test and cardiac hemodynamic variables in HC, HF and HT participants.
| Cardiopulmonary and | HF | HT | HC | HF vs. HT | HF vs. HC | HT vs. HC | |
|---|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | |||||
| Peak power output (watts) | 87.27 ± 26.96 | 134.09 ± 66.96 | 225.77 ± 54.42 | <0.0001 | 0.051 | <0.0001 | 0.002 |
| 1346 ± 316 | 1981 ± 626 | 2780 ± 606 | <0.0001 | 0.009 | <0.0001 | 0.005 | |
| 17.60 ± 4.31 | 26.46 ± 10.12 | 37.69 ± 7.27 | <0.0001 | 0.019 | <0.0001 | 0.007 | |
| RER | 1.14 ± 0.09 | 1.12 ± 0.09 | 1.16 ± 0.08 | 0.480 | - | - | - |
| HRpeak (bpm) | 113.91 ± 20.81 | 138.27 ± 21.28 | 157.15 ± 11.47 | <0.0001 | 0.013 | <0.0001 | 0.019 |
| O2 pulse (mLO2/bpm) | 12.02 ± 2.40 | 14.17 ± 3.15 | 17.70 ± 3.72 | 0.001 | 0.122 | <0.001 | 0.011 |
| SBPpeak (mmHg) | 141.4 ± 19.7 | 176.8 ± 22.6 | 184.8 ± 23.8 | <0.0001 | 0.001 | <0.0001 | 0.384 |
| DBPpeak (mmHg) | 68.5 ± 6.3 | 74.1 ± 7.7 | 78.6 ± 11.6 | 0.032 | 0.076 | 0.014 | 0.267 |
| CIpeak (L/min/m2) | 5.35 ± 1.50 | 6.97 ± 1.52 | 7.98 ± 1.05 | <0.001 | 0.008 | <0.0001 | 0.080 |
| COpeak (L/min) | 10.29 ± 2.89 | 13.11 ± 2.57 | 14.51 ± 2.13 | 0.001 | 0.013 | <0.001 | 0.185 |
| LCWipeak (kg.m/m2) | 6.50 ± 2.55 | 9.85 ± 2.42 | 11.38 ± 2.28 | <0.0001 | 0.003 | <0.0001 | 0.131 |
| 918 ± 170 | 1309 ± 284 | 2108 ± 528 | <0.0001 | 0.002 | <0.0001 | <0.001 | |
| Power at VT1 (watts) | 51.36 ± 17.62 | 69.90 ± 27.20 | 162.08 ± 47.79 | <0.0001 | 0.086 | <0.0001 | <0.0001 |
VT1: first ventilatory threshold. RER: respiratory exchange ratio. HRpeak: heart rate at peak exercise. SBP/DBP: systolic and diastolic blood pressure. CI: cardiac index. CO: cardiac output. LCWi: left cardiac workout index.
Neuropsychological variables in HC, HF and HT participants.
| HF | HT | HC | HF vs. HT | HF vs. HC | HT vs. HC | ||
|---|---|---|---|---|---|---|---|
| Neuropsychological Tests | Mean ± SD | Mean ± SD | Mean ± SD | ||||
| MMSE | 26.82 ± 1.08 | 27.09 ± 2.47 | 28.85 ± 0.90 | <0.001 | 0.742 | <0.0001 | 0.045 |
| Geriatric Depression Scale | 9.18 ± 8.61 | 4.36 ± 2.25 | 3.33 ± 3.28 | 0.140 | - | - | - |
| Forward | 8.91 ± 2.39 | 9.55 ± 1.75 | 10.00 ± 1.21 | 0.396 | - | - | - |
| Backward | 6.45 ± 2.38 | 6.36 ± 1.75 | 7.17 ± 2.29 | 0.622 | - | - | - |
| DSST | 52.45 ± 12.14 | 51.64 ± 14.40 | 69.62 ± 12.15 | 0.002 | 0.883 | 0.003 | 0.002 |
| TMT A (s) | 47.53 ± 15.54 | 38.86 ± 10.81 | 36.34 ± 12.59 | 0.114 | - | - | - |
| TMT B (s) | 112.10 ± 54.53 | 85.21 ± 34.30 | 67.46 ± 17.98 | 0.043 | 0.190 | 0.024 | 0.161 |
| TMT (B-A)/A | 1.33 ± 0.92 | 1.16 ± 0.64 | 0.95 ± 0.44 | 0.397 | - | - | - |
|
| |||||||
| Stroop 1 (s) | 31.19 ± 4.09 | 33.89 ± 5.67 | 29.41 ± 4.96 | 0.135 | - | - | - |
| Stroop 2 (s) | 22.63 ± 4.57 | 23.39 ± 4.33 | 20.10 ± 3.35 | 0.144 | - | - | - |
| Stroop 3 (s) | 72.39 ± 9.60 | 63.28 ± 9.19 | 52.05 ± 11.02 | <0.001 | 0.041 | <0.0001 | 0.011 |
| Stroop 4 (s) | 74.21 ± 13.51 | 73.22 ± 17.76 | 55.86 ± 16.18 | 0.014 | 0.884 | 0.010 | 0.014 |
|
| |||||||
| Immediate recall | 6.55 ± 2.25 | 8.18 ± 4.29 | 10.38 ± 3.04 | 0.009 | 0.280 | 0.002 | 0.171 |
| Delayed recall | 6.40 ± 2.32 | 9.45 ± 3.42 | 10.00 ± 2.37 | 0.013 | 0.017 | 0.006 | 0.647 |
| Rey 1–5 total words | 35.18 ± 5.46 | 46.82 ± 8.65 | 51.62 ± 8.11 | <0.0001 | 0.001 | <0.0001 | 0.132 |
|
| |||||||
| Working memory | −0.21 ± 1.11 | −0.06 ± 0.82 | 0.25 ± 0.60 | 0.425 | - | - | - |
| Processing speed | 0.26 ± 0.61 | 0.28 ± 0.78 | −0.43 ± 0.73 | 0.029 | 0.958 | 0.024 | 0.021 |
| Executive functioning | 0.59 ± 0.63 | 0.14 ± 0.75 | −0.63 ± 0.60 | <0.001 | 0.120 | <0.0001 | 0.008 |
| Verbal memory | −0.78 ± 0.53 | 0.12 ± 0.99 | 0.56 ± 0.78 | 0.001 | 0.012 | <0.001 | 0.178 |
MMSE: Mini-Mental State Examination. DSST: Digit Symbol Substitution Test. TMT: Trail Making Test. RAVL: Rey auditory verbal learning test.
Figure 1The mediating effect of cardiorespiratory fitness (O2peak) on the relationship between group and executive function (A) and processing speed (B). The categorical variable group has three levels: healthy controls are coded as 0, heart failure as 1 and heart transplant as 2. The healthy control group is the reference group. an path is the effect of group on O2peak and b path is the effect of O2peak on executive functioning. cn is the total effect of group on executive functioning and c’n is the direct effect of group on executive functioning.